SARAS CAPITAL
Venture capitalActively deployingCanterbury · 1 people tracked
Find your way into SARAS CAPITAL
1,613 people in our graph share verified history with the SARAS CAPITAL team — schools, employers, funds. One of them is your warm intro.
Fund manager profile
SARAS CAPITAL is a venture fund manager based in Canterbury. SEC filings show 2 venture funds on record, most recently SARAS CAPITAL II LP filed December 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directories
What they invest in
from 11 of 11 portfolio companiesAI & Machine Learning ×7Biotech ×5Enterprise Software ×4Deep Tech ×3SaaS ×3Data & Infrastructure ×2Developer Tools ×2Healthtech ×2
HQs:United States×5United Kingdom×2Germany×1France×1
Investments · 11 tracked
founders shown can be your intro pathBy year:2026 · 42025 · 12022 · 16 dated
Kyron.bio is a biotechnology company focused on developing therapeutic drugs, with an in-house R&D and laboratory operation.
BiotechDeep TechHealthtechParis, FR
Emilia McLaughlin(Cofounder)in
Co-investorsEntrepreneur FirstHCVCVerve VenturesGSV Ventures
.jpeg){kind=logo}
NanoSyrinx develops a technology platform for biopharmaceutical applications, with expertise in drug discovery, cell therapy, and biologic development.
AI & Machine LearningBiotechDeep TechMedical DevicesCoventry, GB
Dr. Joe Healey(Founder)Dr. Nick Waterfield(Founder)Dr. Alexia Hapeshi(Founder)Joe(Founder and former CEO)Nick(Scientific Advisor and Co-founder)Thomas J. Farrell(CEO)
Co-investorsIQ CapitalOctopus VenturesFuture Planet CapitalM Ventures
.jpeg){kind=logo}
Graphica applies foundational AI models to precision plant breeding, genetics and molecular biology, building plants and biological products.
AgTechAI & Machine LearningBiotechLondon, GB
Cecy Price(CEO)inDominic Hall(CTO)in
Co-investorsEntrepreneur FirstFaberFaber Capital SCR SASie VenturesSuperSeedCardumen Capital+4 more
Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE
Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel
Co-investorsFrontline VenturesPace VenturesY CombinatorSpringboard Health Angels
Converge is an AI-native growth platform for direct-to-consumer brands that automates media buying, attribution analysis, and reporting through agentic AI.
AdTechAI & Machine LearningDirect to ConsumerE-commerceEnterprise SoftwareSaaSNew York City, US
Jan-Henrik Lambrechts(Founder)inJerome Billiet(Founder)inThomas Holvoet(Founder)in
Co-investorsEntourage VenturesY CombinatorBessemer Venture PartnersTLV PartnersVintage Investment Partners
Converge is an insurtech company that underwrites cyber risk insurance, distributing coverage to broker-partners across the U.S. through a capacity partnership with QBE.
AI & Machine LearningCybersecurityFintechInsurTech
Steven Petrevski(Founder)inTom Kang(Chief Executive Officer)Howie Altman(Chief Technology Officer)in
Co-investorsForgePoint CapitalBessemer Venture PartnersTLV PartnersVintage Investment Partners
Converge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies.
AI & Machine LearningBiotechDeep TechClaymont, US
Dov Gertz(CEO & Co-Founder)inOded Kalev(CTO & Co-Founder)inIddo Weiner(CSO & Co-Founder)in
BoardShahar Tzafrir(Director)inAndrew Hedin(Director)in
Co-investorsBessemer Venture PartnersTLV PartnersVintage Investment Partners
Eden Bio develops machine-learning technology for genetic engineering and protein yield optimization across food, pharmaceutical, and biofuel industries.
AI & Machine LearningBiotech
Co-investorsSynBioVenUnruly Capital
Parse provides cloud-based backend infrastructure and tools for developers to build applications across mobile, desktop, and embedded platforms, including data storage, push notifications, and usage analytics.
Developer ToolsEnterprise SoftwareSan Francisco, US
Kevin Lacker(Founder/CTO)in
Co-investorsY Combinator
Parse provides an API platform that converts web actions and data retrieval from any website into single API calls without running a browser.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Alex Forman(Founder)in
Co-investorsY Combinator
Parse.ly is a content analytics and audience intelligence platform offering a real-time dashboard, a content recommendation API, a data pipeline to warehouses, and AI-driven insights.
Data & InfrastructureMarketing TechMedia & Entertainment
Co-investorsHaatchHorizon Technology FinanceJanus Henderson InvestorsSahsen VenturesSoleus Capital
Portfolio news
latest coverage across their companiesConverge · businessmirror.com.ph · Jul 15, 2026
Converge Bio · startupintros.com · Jul 13, 2026
Kyron · biopharminternational.com · May 15, 2026
Converge · techcrunch.com · Jan 13, 2026
Biographica · tech.eu · Jan 7, 2026
Parse · ycombinator.com · Nov 8, 2025
Frequently asked questions
- How many investments has SARAS CAPITAL made?
- SARAS CAPITAL has 11 tracked investments, 1 of which have exited, including 5 dated in the last 24 months.
- Where is SARAS CAPITAL located?
- SARAS CAPITAL is headquartered in Canterbury.